Listed by the USPTO as YU, DELPHINUS DOU YI
Tech Center 1600 • Art Units: 1631 1634 1636 1645 1651 1656
This examiner grants 33% of resolved cases
YU, DELPHINUS DOU YI examines in Tech Center 1600, Art Unit 1631. The profile records 6 resolved cases, a 33.3% allowance rate, and a 0.0% interview lift. The median days to allowance are 1026.
The listed companies are Virginia Commonwealth University, Alnylam Pharmaceuticals Inc., and Editas Medicine Inc. The listed firms are BALLARD SPAHR LLP, MCCARTER & ENGLISH, LLP, and WC&F IP. The limited record gives little basis for generalized prosecution predictions. Practitioners should use the profile as background and base decisions on the particular claims, references, and response history.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18452127 | HIGH-THROUGHPUT METHODS FOR ANALYZING AND AFFINITY-MATURING AN ANTIGEN-BINDING MOLECULE | Non-Final OA | 10x Genomics, Inc. |
| 17909341 | Artificial Chromosome Vector and Use Thereof | Final Rejection | The University of Tokyo |
| 18271631 | GENETIC THERAPY FOR GLAUCOMA AND OPTIC NEUROPATHIES | Final Rejection | The United States Government as Represented by The Department of Veterans Affairs |
| 18520481 | PROTACS WITH TRANSCRIPTION FACTOR TARGETING MOIETIES | Non-Final OA | Icahn School of Medicine at Mount Sinai |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.3% of resolved applications examined by Delphinus Dou Yi Yu were allowed (6 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Delphinus Dou Yi Yu took 1,026 days on average from filing to allowance.
Delphinus Dou Yi Yu examines applications in Art Unit 1631 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
